Extended Data Fig. 4: Changes in circulating surrogate tumor markers correlate with radiographic tumor response. | Nature Medicine

Extended Data Fig. 4: Changes in circulating surrogate tumor markers correlate with radiographic tumor response.

From: Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results

Extended Data Fig. 4: Changes in circulating surrogate tumor markers correlate with radiographic tumor response.

SMRP was measured in plasma using the Mesomark™ assay and MPF was measured in plasma using an ECL assay and ctDNA was measured using a plasma based NGS assay. Comparative analysis of a, best SMRP response (n = 25 independent patient samples, **p = 0.074 by two-tailed Mann Whitney t test. and b, best MPF response in responders vs. non-responders. (n = 29 independent patient samples). For both a, and b, patients classified as non-evaluable by RECIST response were excluded from the analysis. For both box-plots; center line, box limits and whiskers represent the median, interquartile range and minima and maxima, respectively. c, Longitudinal changes in ctDNA levels in selected patients.

Source data

Back to article page